EricJohnHuseltonMD
Hematology • Rochester, NYHematologic Oncology
Assistant Professor, Leukemia/Blood and Marrow Transplant Program
Dr. Huselton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-5823Fax+1 585-273-1051
Summary
- Dr. Eric Huselton is a hematologist in Rochester, NY and is affiliated with Strong Memorial Hospital of the University of Rochester. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 5 years. He specializes in hematologic oncology and is experienced in hematologic oncology, leukemia, and stem cell transplant.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2015 - 2018- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015
State University of New York Downstate Medical Center College of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2018 - 2025
MO State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance Start of enrollment: 2016 Jul 06
- CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia Start of enrollment: 2017 Apr 07
- Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS Start of enrollment: 2020 Feb 17
Publications & Presentations
PubMed
- Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes.Marissa LoCastro, Andrea Baran, Jane Liesveld, Eric Huselton, Elaine Hill
JCO Oncology Practice. 2024-12-16 - Clinicians' Perspectives on the Telehealth Serious Illness Care Program for Older Adults With Myeloid Malignancies: Single-Arm Pilot Study.Marissa LoCastro, Ying Wang, Tristan Yu, Soroush Mortaz-Hedjri, Jason Mendler
JMIR Formative Research. 2024-06-27 - Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia.Marissa LoCastro, Marielle Jensen-Battaglia, Chandrika Sanapala, Rachel Rodenbach, Jason H Mendler
Journal of Geriatric Oncology. 2024-06-01
Abstracts/Posters
- Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant CyclophosphamideEric Huselton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDSClinically Relevant Abst...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- CX-01, an inhibitor of CXCL12/CXCR4 axis and of platelet factor 4 (PF4), with azacitidine (AZA) in patients with hypomethylating agent (HMA) refractory AML and MDS.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Suny Downstate Internal Medicine ResidencyJune 29th, 2020- Suny Downstate Internal Medicine ResidencyDecember 24th, 2020
Suny Downstate Internal Medicine ResidencyMarch 7th, 2021- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
